Pictures of Mild to Moderate Ulcerative Colitis
Links shared publicly online about this topic
Colitis, Ulcerative on #MDlinx
mdlinx.com — “Colitis, Ulcerative on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 20, 2010 at 10:27 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oral 5-aminosalicylic acid therapy for mild-to-moderate ulcerative colitis: Journal of the American Acade... http://bit.ly/9BdFDn #medicine
Colitis, Ulcerative on #MDlinx
mdlinx.com — “Colitis, Ulcerative on #MDlinx” View full resource at mdlinx.com
Most Recently Shared on October 20, 2010 at 1:17 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Oral 5-aminosalicylic acid therapy for mild-to-moderate ulcerative colitis: Journal of the American Academy of ... http://bit.ly/a7P2RB #GI
Family Medicine Article | Colitis, Ulcerative
mdlinx.com — “Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maintenance of remission using mesalazine” View full resource at mdlinx.com
Most Recently Shared on November 25, 2010 at 7:35 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Best practice in the management of mild-to-moderately active ulcerative colitis and achieving maint... http://bit.ly/hjPsrn #FamPractice
Phase 3 Study of Uceris for Ulcerative Colitis - MPR
empr.com — “Santarus, Inc. announced pooled data from two Phase 3 studies of Uceris (budesonide MMX) for the induction of remission of mild or moderate active ulcerative colitis.” View full resource at empr.com
Most Recently Shared on November 1, 2011 at 7:30 pm By:
Phase 3 Study of Uceris for Ulcerative #Colitis http://t.co/PLaOXrl5
NDA Accepted for Uceris for Ulcerative Colitis - MPR
empr.com — “Santarus, Inc. announced that the FDA has accepted its New Drug Application (NDA) for Uceris (budesonide) tablets 9mg for the induction of remission of mild to moderate active ulcerative colitis.” View full resource at empr.com
Most Recently Shared on February 15, 2012 at 3:48 pm By:
NDA Accepted for Uceris for Ulcerative #Colitis http://t.co/E7KvyM2M #colorectal #gastrointestinal
How Is Ulcerative Colitis Characterized? | AsacolHD.com
asacolhd.com — “Learn more about how ulcerative colitis is characterized.” View full resource at asacolhd.com
Most Recently Shared on April 26, 2010 at 12:58 pm By:
Most people with UC have a mild to moderate form of the condition. Learn how ulcerative colitis is characterized. http://bit.ly/dcoQPY
Shire Canada receives expanded indication for MEZAVANT in treatment of ulcerative colitis
news-medical.net — “Shire Canada Inc., a division of Shire plc, the global specialty biopharmaceutical company, is proud to announce that MEZAVANT® (mesalamine delayed and extended release tablets), the first and only once-daily mesalamine indicated for the induction of clinical and endoscopic remission in patients with mild-to-moderate, active ulcerative colitis (UC), has received an expanded indication to include maintenance of clinical and endoscopic remission (mucosal healing) in patients with ulcerative c” View full resource at news-medical.net
Most Recently Shared on June 7, 2011 at 2:39 pm By:
Shire Canada receives expanded indication for MEZAVANT in treatment of ulcerative colitis: Shire Canada Inc., a ... http://bit.ly/iQsVXv
Santarus and Cosmo Announce Positive Top-Line Results in U.S. Phase III Clinical Study Evaluating Budesonide MMX in Ulcerative Colitis - Drugs.com MedNews
drugs.com — “Companies Expect to Announce European Phase III Study Results in November Extended Use Study is Ongoing Sep 29, 2010 - Santarus, Inc. (NASDAQ SNTS) and Cosmo Ph” View full resource at drugs.com
Most Recently Shared on September 30, 2010 at 8:08 pm By:
Drugs and Devices OW OW Health
Santarus and Cosmo Announce Positive Top-Line Results in U.S. Phase III Clinical Study Evaluating Budesonide ... http://bit.ly/c3kwaA #drug
Santarus Announces Positive Top-Line Results in E.U. Phase III Clinical Study Evaluating Budesonide MMX in Ulcerative Colitis - Drugs.com MedNews
drugs.com — “NDA filing planned in second half of 2011 following completion of extended use study Conference call to begin at 4 30 p.m. Eastern time today Nov 8, 2010 - Sant” View full resource at drugs.com
Most Recently Shared on November 10, 2010 at 3:12 pm By:
Drugs and Devices OW OW Health
Santarus Announces Positive Top-Line Results in E.U. Phase III Clinical Study Evaluating Budesonide MMX in... http://bit.ly/depPDg #drug
First sulfite-free rectal suspension for UC
news-medical.net — “sfRowasa" (mesalamine) Rectal Suspension 4g/60mL "Sulfite-Free Formulation, is the first sulfite-free rectal suspension available for Ulcerative colitis (UC). According to a study published in The American Journal of Gastroenterology, products containing sulfites may exacerbate natural sulfide levels in the colon and may increase inflammation in UC patients. With its sulfite-free preparation, sfRowasa" offers a new treatment option for the treatment of active, mild to moderate distal ulcerative ” View full resource at news-medical.net
Most Recently Shared on January 13, 2010 at 7:07 am By:
First sulfite-free rectal suspension for UC: sfRowasa™ (mesalamine) Rectal Suspension 4g/60mL –Sulfite-Free Formul... http://bit.ly/5sqzth
Electronic Pill Shows Its Smarts by Measuring pH Levels in Digestive Tract
newswise.com — “An electronic diagnostic tool called the SmartPill is swallowed by patients in order to take measurements as it travels through the gastrointestinal tract. A new study by physician-scientists at NewYork-Presbyterian/Weill Cornell Medical Center used the device in patients with mild to moderate ulcerative colitis (UC), determining that they have significantly more acidic pH in their colons, compared with the average person -- a finding that may impact treatment strategy.” View full resource at newswise.com
Most Recently Shared on June 3, 2009 at 8:25 pm By:
Electronic Pill Shows Its Smarts by Measuring pH Levels in Digestive Tract http://bit.ly/D2LvY
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
-
Sandeep Pulim MD
Over 2K medical journal articles & health news summarized and delivered FREE to 35 specialties daily. Oncology, Rheumatology, Cardiology, Neurology, Psychiatry
Advertisement
